NCT05951387View on ClinicalTrials.gov

Dexmedetomidine Versus Dexmedetomidine with Ketamine in Mechanically Ventilated ARDS Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

June 1, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

June 5, 2024

Conditions
Haemodynamic Instability
Interventions
DRUG

dexmedetomidine plus ketamine

titrating the dose of dexmedetomidine mixed with ketamine (staring dose 0.5ug/kg/hr, 0.5mg/kg/hr respectively)to achieve full sedation

DRUG

Dexmedetomidine

starting intravenous infusion with dexmedetomidine starting at dose 0.5ug/kg//hr and titrate the dose to achieve full sedation

Trial Locations (1)

13511

Benha university, Banhā

All Listed Sponsors
lead

Benha University

OTHER

NCT05951387 - Dexmedetomidine Versus Dexmedetomidine with Ketamine in Mechanically Ventilated ARDS Patients | Biotech Hunter | Biotech Hunter